Phreesia, Inc. (NYSE:PHR) Given Average Rating of “Moderate Buy” by Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have been given a consensus recommendation of “Moderate Buy” by the nineteen research firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and seventeen have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $29.7647.

Several research analysts have recently commented on the company. JPMorgan Chase & Co. cut their price objective on Phreesia from $32.00 to $29.00 and set an “overweight” rating for the company in a report on Tuesday, December 9th. DA Davidson dropped their target price on shares of Phreesia from $35.00 to $30.00 and set a “buy” rating for the company in a research report on Friday. Truist Financial set a $24.00 price target on shares of Phreesia in a report on Thursday, January 8th. Canaccord Genuity Group lowered their price target on Phreesia from $38.00 to $33.00 and set a “buy” rating on the stock in a research report on Tuesday, December 9th. Finally, Wells Fargo & Company assumed coverage on shares of Phreesia in a report on Thursday, January 8th. They issued an “overweight” rating and a $30.00 price objective for the company.

Phreesia Trading Up 0.1%

Phreesia stock opened at $15.82 on Monday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.44 and a current ratio of 2.44. Phreesia has a fifty-two week low of $15.40 and a fifty-two week high of $32.76. The stock has a market cap of $953.97 million, a P/E ratio of -158.21 and a beta of 0.61. The firm’s fifty day moving average price is $17.69 and its 200-day moving average price is $22.82.

Phreesia (NYSE:PHR) last posted its earnings results on Monday, December 8th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.11. The business had revenue of $120.33 million during the quarter, compared to analysts’ expectations of $119.98 million. Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The firm’s revenue was up 12.7% on a year-over-year basis. During the same period in the previous year, the business earned ($0.25) earnings per share. Equities research analysts forecast that Phreesia will post -1.1 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Balaji Gandhi sold 4,687 shares of the firm’s stock in a transaction that occurred on Friday, January 16th. The shares were sold at an average price of $16.36, for a total value of $76,679.32. Following the transaction, the chief financial officer owned 150,569 shares in the company, valued at approximately $2,463,308.84. This trade represents a 3.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider David Linetsky sold 6,038 shares of the firm’s stock in a transaction on Friday, January 16th. The stock was sold at an average price of $16.36, for a total transaction of $98,781.68. Following the completion of the sale, the insider directly owned 223,942 shares in the company, valued at approximately $3,663,691.12. This trade represents a 2.63% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 60,766 shares of company stock valued at $1,013,817. Corporate insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Phreesia

Large investors have recently made changes to their positions in the business. Federated Hermes Inc. purchased a new position in shares of Phreesia during the third quarter valued at approximately $32,000. Asset Management One Co. Ltd. purchased a new position in Phreesia during the 3rd quarter valued at $45,000. State of Alaska Department of Revenue purchased a new position in Phreesia during the 3rd quarter valued at $83,000. Farther Finance Advisors LLC raised its holdings in Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after purchasing an additional 3,000 shares in the last quarter. Finally, Anchor Investment Management LLC bought a new position in Phreesia in the 3rd quarter worth $118,000. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.